FindTrial
Sign In

Dexmedetomidine-based total intravenous anesthesia for total abdominal hysterectomy: the effect on postoperative analgesia and postoperative nausea and vomiting

Dexmedetomidine-based total intravenous anesthesia for total abdominal hysterectomy: the effect on postoperative analgesia and postoperative nausea and vomiting

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15005893
Enrollment
Unknown
Registered
2015-01-19
Start date
2015-01-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain and nausea/vomiting

Interventions

Fentanyl group :Fentanyl
Dexmedetomidine group :Dexmedetomidine

Sponsors

Pekoing Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Female patients undergoing total abdominal hysterectomy, ASA I-II

Exclusion criteria

Exclusion criteria: Allergy to morphine, renal or hepatic dysfunction, current smoker, history of motion sickness and/or PONV, ischemic or valvular heart disease, chronic use of any opioid analgesics, sedatives or tricyclic antidepressants, psychiatric illness, alcohol abuse or the inability to understand the use of a patient-controlled analgesia (PCA) device.

Design outcomes

Primary

MeasureTime frame
Postoperative morphine consumption;PONV;postoperative VAS;—

Countries

China

Contacts

Public ContactZhang Xiuhua
xiuzhangpumch@aliyun.com+86 18612671788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026